Hosted on MSN15d
The European Medicines Agency EMA has not 'admitted' that mRNA vaccines are 'experimental'
The website also takes issue with this line in the paper: "mRNA vaccines and their manufacturing process are a novel ...
States eye mRNA vaccine limits for a hesitant public
Christopher Ridley, a spokesperson for Moderna, said the state legislative efforts are largely a product of ...
Moderna: Patent Litigation Win Masks Underperformance, Unlikely To Pay Out
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...
Cartesian Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...
GEN - Genetic Engineering and Biotechnology News14d
The Characterization of Lipid Components in Lipid Nanoparticle Formulations
1. Characterization of lipid components in lipid nanoparticle (LNP) formulations – Application Note AN001928 – ...
Kansas City Star29d
Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
Expects 2025 revenue range of $1.5 to 2.5 billion andending cash balance of approximately $6 billion Submitted three investigational mRNA products for regulatory approval, including Moderna's next ...
News Medical5d
Connect with over 100 specialists in mRNA process development
Learn about Altamira and Divincell's cutting-edge formulation techniques for thermostable mRNA products, which reduce cold chain dependencies and increase global accessibility. Do not pass up the ...